Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
17 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 27
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Europe
🇪🇸 SpainOfficialMA, national code, safety/supply boundaryEU/Spanish frameworkLatest observed: current
🇪🇸 SpainOfficialMA, national code, safety/supply boundaryEU/Spanish frameworkLatest observed: current
🇪🇸 SpainOfficialIPT network/current bridgefrom 2013Latest observed: current publications 2026
🇪🇸 SpainOfficialOffice, clinical/non-clinical, 70+70, non-binding, transitioneffective 2026-06-18Latest observed: consolidated current
🇪🇸 SpainOfficialfinancing criteria, CIPM, price, CCAA equality, confidentiality, lifecyclecurrent consolidated lawLatest observed: through 2026
🇪🇸 SpainOfficialoperational funded products/statusmonthlyLatest observed: June/July 2026
🇪🇸 SpainOfficialindications, restrictions, status, special conditionsmonthly NomenclátorLatest observed: July 2026
🇪🇸 SpainOfficialprovisional decision, allegations, resolution, public reportssession Apr 2026; reports from 2025Latest observed: current
🇪🇸 SpainOfficialprovisional decision, allegations, resolution, public reportssession Apr 2026; reports from 2025Latest observed: current
🇪🇸 SpainOfficialRWE, protocols, PBR boundarycurrentLatest observed: FAQ 2026-03
🇪🇸 SpainOfficialRWE, protocols, PBR boundarycurrentLatest observed: FAQ 2026-03
🇪🇸 SpainOfficialrepresentative CCAA implementationregional frameworkLatest observed: current 2026
🇪🇸 SpainOfficialpharmacy acquisition/dispensing, local committee/formularycurrent law/regional processLatest observed: SAS checked 2026
🇪🇸 SpainOfficialpharmacy acquisition/dispensing, local committee/formularycurrent law/regional processLatest observed: SAS checked 2026
🇪🇸 SpainOfficialcompassionate, foreign, off-label, group accessRD 2009/currentLatest observed: page 2023/current
🇪🇸 SpainOfficialcompassionate, foreign, off-label, group accessRD 2009/currentLatest observed: page 2023/current
🇪🇸 SpainOfficialmature-market price lifecyclecurrent monthly cycleLatest observed: 2026-07-24
🇪🇸 SpainOfficialnational governance and benefit contextdata 2024Latest observed: published 2025/26
🇪🇸 SpainOfficialpolicy-watch only, not current pathconsultation 2026-06-19; bill 2026-07-21Latest observed: current policy proposals
🇪🇸 SpainOfficialpolicy-watch only, not current pathconsultation 2026-06-19; bill 2026-07-21Latest observed: current policy proposals
🇪🇸 SpainOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇪🇸 SpainOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇪🇸 SpainOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇪🇸 SpainOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇪🇸 SpainOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇪🇸 SpainOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
🇪🇸 SpainOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
For education only — not regulatory, pricing or legal advice.